Form 4 for IMAX IMAX CORP

Accepted 2026-04-28 16:15:15 ET · period of report 2026-04-27 · accession 0001214659-26-005177 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DT	2026-04-28 16:15	2026-04-27	IMAX	GELFOND RICHARD L	CEO, Dir	C - Cnv Deriv	$31.40	+8,943	773.9K	+1%	+$280.8K
DT	2026-04-28 16:15	2026-04-27	IMAX	GELFOND RICHARD L	CEO, Dir	S - Sale	$37.33	-8,943	765.0K	-1%	-$333.8K
DT	2026-04-28 16:15	2026-04-27	IMAX	GELFOND RICHARD L	CEO, Dir	C - Cnv Deriv	$31.40	-8,943	1.33M	-0.7%	-$280.8K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	common shares	2026-04-27	C	A	8,943	$31.40	773,945	D	—	—	(F1) Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. Effective April 27, 2026, the sales under the 10b5-1 plan are complete.
2	Common	common shares	2026-04-27	S	D	8,943	$37.33	765,002	D	—	—
3	Derivative	stock options (to buy)	2026-04-27	C	D	8,943	$31.40	1,332,411	D	$31.40 · — to 2026-06-07	8,943 common shares	(F2) These options were issued in 2016 and are set to expire on June 7, 2026. (F3) The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. (F4) This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,332,411, 231,562 and 765,002, respectively.